PlainRecalls
FDA Drug Moderate Class II Terminated

Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-446-90.

Reported: February 12, 2020 Initiated: January 24, 2020 #D-0828-2020

Product Description

Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-446-90.

Reason for Recall

cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement.

Details

Recalling Firm
Ascend Laboratories LLC
Units Affected
192 Bottles
Distribution
Nationwide in the U.S.
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-446-90.. Recalled by Ascend Laboratories LLC. Units affected: 192 Bottles.
Why was this product recalled?
cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 12, 2020. Severity: Moderate. Recall number: D-0828-2020.